Director at Kodiak Sciences (KOD) receives 17,731 stock options award

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Kodiak Sciences Inc. director Robert Profusek received a grant of stock options covering 17,731 shares of common stock. The options have an exercise price of $38.96 per share and expire on June 29, 2036.

All 17,731 option shares vest in full on the earlier of June 30, 2027 or one day before the company’s next annual meeting after the grant date, as long as he continues serving on the board through that vesting date. Following this grant, he holds 17,731 derivative securities directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider PROFUSEK ROBERT

Role null

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	17,731	$0.00	--

Holdings After Transaction: Stock Option (Right to Buy) — 17,731 shares (Direct, null)

Footnotes (1)

[object Object]

Key Figures

Option shares granted: 17,731 shares Exercise price: $38.96 per share Expiration date: June 29, 2036 +3 more

6 metrics

Option shares granted 17,731 shares Stock Option (Right to Buy) grant to director

Exercise price $38.96 per share Stock option exercise price

Expiration date June 29, 2036 Stock option expiration

Underlying common shares 17,731 shares Common stock underlying the option

Total derivative securities held 17,731 options Holdings following transaction

Vesting trigger date June 30, 2027 Earlier of this date or day before next annual meeting

Key Terms

Stock Option (Right to Buy), exercise price, expiration date, vesting, +1 more

5 terms

Stock Option (Right to Buy) financial

"security_title: Stock Option (Right to Buy)"

exercise price financial

"conversion_or_exercise_price: 38.9600"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

expiration date financial

"expiration_date: 2036-06-29T00:00:00.000Z"

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

vesting financial

"shares subject to the option shall vest upon the earlier of June 30, 2027"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

underlying security financial

"underlying_security_title: Common Stock"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/02/2026 - 05:57 PM Accepted by SEC EDGAR 07/02/2026 - 05:57 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

PROFUSEK ROBERT

(Last)

(First)

(Middle)

1250 PAGE MILL ROAD

(Street)

PALO ALTO

CALIFORNIA

94304

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Kodiak Sciences Inc. [ KOD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (Right to Buy)	$38.96	06/30/2026		A		17,731		⁽¹⁾	06/29/2036	Common Stock	17,731	$0	17,731	D

Explanation of Responses:

1. One hundred percent (100%) of the shares subject to the option shall vest upon the earlier of June 30, 2027 or one (1) day prior to the Issuer's next annual meeting occurring after the grant date, in each case, provided the Reporting Person continues to serve as a member of the Issuer's board of directors through the applicable vesting date.

	/s/ David Peinsipp, Attorney-in-Fact for Robert Profusek	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Kodiak Sciences (KOD) report for Robert Profusek?

Kodiak Sciences reported that director Robert Profusek received a grant of stock options. The award covers 17,731 shares of common stock and is structured as a compensation-related grant, not an open-market purchase or sale of Kodiak Sciences shares.

How many Kodiak Sciences (KOD) stock options were granted to Robert Profusek?

Robert Profusek was granted stock options covering 17,731 shares of Kodiak Sciences common stock. These options give him the right to buy the same number of shares in the future, subject to vesting conditions and the stated exercise price and expiration date.

What is the exercise price and expiration date of the Kodiak Sciences (KOD) options?

The stock options granted to Robert Profusek have an exercise price of $38.96 per share and expire on June 29, 2036. This means he may purchase Kodiak Sciences shares at $38.96 if the options are vested and exercised before expiration.

When do Robert Profusek’s Kodiak Sciences (KOD) options vest?

All 17,731 stock option shares vest 100% on the earlier of June 30, 2027 or one day before Kodiak Sciences’ next annual meeting after the grant date. Vesting requires that he continue serving as a member of the board through the applicable vesting date.

Is Robert Profusek’s Form 4 transaction in Kodiak Sciences (KOD) a purchase or a grant?

The Form 4 transaction for Robert Profusek is classified as a grant or award acquisition of stock options. It reflects a compensation-related award from Kodiak Sciences, not an open-market purchase, and is coded as an “A” transaction for an option grant.

How many Kodiak Sciences (KOD) derivative securities does Robert Profusek hold after the grant?

After this option grant, Robert Profusek holds 17,731 derivative securities related to Kodiak Sciences, all from this stock option award. These options correspond to 17,731 underlying common shares, contingent on vesting and any future exercise decisions.